Articles with "rad51c" as a keyword



Photo from wikipedia

Characterisation of the novel deleterious RAD51C p.Arg312Trp variant and prioritisation criteria for functional analysis of RAD51C missense changes

Sign Up to like & get
recommendations!
Published in 2017 at "British Journal of Cancer"

DOI: 10.1038/bjc.2017.286

Abstract: Background:Despite a high prevalence of deleterious missense variants, most studies of RAD51C ovarian cancer susceptibility gene only provide in silico pathogenicity predictions of missense changes. We identified a novel deleterious RAD51C missense variant (p.Arg312Trp) in… read more here.

Keywords: rad51c; missense changes; rad51c missense; missense ... See more keywords
Photo from wikipedia

Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants

Sign Up to like & get
recommendations!
Published in 2022 at "Proceedings of the National Academy of Sciences of the United States of America"

DOI: 10.1073/pnas.2202727119

Abstract: Significance The RAD51 paralog RAD51C is among the homologous recombination (HR) genes known to be tumor suppressors. As with many tumor suppressors, a large number of variants of unknown significance have been identified, impairing informed… read more here.

Keywords: rad51c; cluster; tumor; cancer ... See more keywords
Photo from wikipedia

Functional analysis of germline RAD51C missense variants highlight the role of RAD51C in replication fork protection.

Sign Up to like & get
recommendations!
Published in 2022 at "Human molecular genetics"

DOI: 10.1093/hmg/ddac281

Abstract: Monoallelic or biallelic RAD51C germline mutations results in chromosome instability disorders such as fanconi anemia (FA) and cancers. The bona fide function of RAD51C is to assist RAD51 nucleoprotein filament onto single strand DNA to… read more here.

Keywords: rad51c; replication; replication fork; fork protection ... See more keywords
Photo from wikipedia

Exceptional response to FOLFIRINOX in a patient with pancreatic cancer and a germline RAD51C mutation.

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of gastrointestinal oncology"

DOI: 10.21037/jgo.2018.03.11

Abstract: Pancreatic cancer is projected to become the second leading cause of cancer death in the United States by 2030. Deleterious germline mutations can contribute to pancreatic cancer susceptibility. Herein we report a case of a… read more here.

Keywords: response; rad51c; pancreatic cancer; cancer ... See more keywords